The United States Rheumatic Diseases Therapeutics Market

Published by: Frost & Sullivan

Published: Aug. 28, 2012 - 121 Pages


Table of Contents

Executive Summary
Market Overview
Rheumatic Diseases Therapeutics Market
External Challenges: Drivers and Restraints
Forecasts and Trends
Demand Analysis
Market Share and Competitive Analysis
Rheumatoid Arthritis Segment Breakdown
Psoriatic Arthritis Segment Breakdown
Ankylosing Spondylitis Segment Breakdown
The Last Word (Conclusions and Implications)
ppendix

Abstract

This research service covers the therapeutics for rheumatic diseases market in the United States from 2009 to 2017, with 2011 as the base year. The focus of this research is on biologics and other treatments prescribed as add-on therapies for rheumatoid arthritis (RA), psoriatic arthritis (PsA), and ankylosing spondylitis (AS); background standard of care therapies are not covered in this study. Included in the study are products already on the market and products in development as well as patient and revenue forecasts. Market challenges, drivers, and restraints are identified and assessed. The market is segmented by disease indication: RA, PsA, and AS.

Get full details about this report >>
 
Learn more about this product


Price and delivery options
See related reports or call the number below for help from a research specialist.

US: 800.298.5699

Int'l: +1.240.747.3093

 

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 400,000 market research reports, company profiles and country profiles from over 720 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.